Yes. I would clarify is that it's not for our industry; it's for Canadians and for payers of medicines. You have public payers and you have private payers. The way it would work in the private industry is that you have employers ultimately paying, and Canadians paying for their drugs. It may be facilitated through an insurance company, but really, lower prices would be to the benefit of both employers and Canadians, as well as the public payers—governments.
On October 4th, 2018. See this statement in context.